About Sniper Sniper
Sniper Medical Technologies is an innovative medical device company focused on the development and commercialization of digital PCR platforms and precision molecular diagnostic solutions.
Founded in 2018 and headquartered in Suzhou, China, Sniper is committed to making high-sensitivity, reproducible and standardized molecular testing more accessible for clinical laboratories worldwide.
Our Mission
To provide accessible and precise diagnostic solutions for everyone.
Through platform-level innovation in digital PCR, Sniper aims to support more reliable molecular testing in clinical diagnostics, precision medicine and public health.
Making an Impact
Turning digital PCR innovation into clinical and commercial value.
Sniper integrates proprietary technology, regulated product development, manufacturing capability and global collaboration to help laboratories adopt digital PCR in real-world diagnostic settings.
VibroJet®
Proprietary digital PCR technology
3 Sites
R&D and manufacturing presence in Suzhou, Beijing and Taicang
Global Reach
Regulatory and commercial milestones across major markets
Core Technology
VibroJet® Digital PCR Technology
At the core of Sniper’s platform is VibroJet®, a proprietary vibration-injection digital PCR technology. It supports automated droplet generation, absolute quantification and high-sensitivity detection, enabling digital PCR to be applied more efficiently in clinical molecular diagnostics.
Regulatory and Quality System
Built for clinical use and global compliance
Sniper’s digital PCR platform has obtained China NMPA registration, U.S. FDA clearance and CE marking in the European Union. Supported by ISO 13485 certification, Sniper has established a robust quality and regulatory framework for global clinical and commercial deployment.
Clinical Applications
Digital PCR solutions for high-value molecular testing
Sniper’s digital PCR platform is designed to support demanding clinical applications, including:
- Hematologic malignancy monitoring
- Minimal residual disease monitoring
- Solid tumor liquid biopsy
- Complex infectious disease testing
By delivering precise and reproducible quantification, Sniper helps laboratories generate more confident molecular results for clinical decision-making.
Manufacturing and Supply Capability
From innovation to stable delivery
This end-to-end capability supports long-term cooperation with hospitals, laboratories, distributors and diagnostic partners.
Our Vision
Sniper aims to help establish next-generation digital molecular testing standards through continuous innovation in digital PCR technology, clinical applications and global collaboration.
Our Culture
Sniper is driven by clinical needs, grounded in regulatory quality and committed to practical innovation. We work closely with partners to translate advanced molecular technologies into accessible diagnostic solutions.
Core Values
Openness to global collaboration
Continuous improvement
About Milestones
To become a globally trusted technical standard-setter and solution provider in the field of molecular diagnostics,
and to build a life science company that can thrive for a hundred years.
2018
2021
2023
2025
2020
2022
2024
2026
Work With Sniper
We welcome collaboration with clinical laboratories, hospitals, distributors, diagnostic companies, research institutions and strategic partners worldwide. Together, we can expand the clinical adoption of digital PCR and bring more precise molecular testing to real-world healthcare settings.
Talk to Our Team
Tell us about your laboratory, application area, or partnership interest, and our team will connect you with the right product or collaboration pathway.
You can also reach us directly at
- 0512-62809514
- sniperorder@sniper-tech.com